Myostatin & Activin A Blockade: A New Way to Improve Weight Loss Quality on GLP-1 Drugs?
Summary of Findings from a 2025 Nature Communications Study GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) have revolutionized obesity treatment. However, these drugs don’t just burn fat — they also strip away muscle mass. In fact, up to 40% of weight lost on GLP-1s can come from lean tissue, especially muscle. This muscle loss can […]
Myostatin & Activin A Blockade: A New Way to Improve Weight Loss Quality on GLP-1 Drugs? Read More »